Emergex has secured a 'state-of-the-art' research and development (R&D) facility and hired a new chief scientific officer to drive development of its vaccines.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.